Literature DB >> 11295570

Rapid actions of plasma membrane estrogen receptors.

M J Kelly1, E R Levin.   

Abstract

Functional evidence for the existence of plasma membrane estrogen receptors in a variety of cell types continues to accumulate. Many of these functions originate from rapid signaling events, transduced in response to 17beta-estradiol (E(2)). It has been convincingly shown that E(2) activates phosphoinositol 3-kinase and protein kinase B/AKT, and stimulates ERK and p38 MAP kinases. In part, this stems from G-protein activation and the resulting calcium flux. As a result, the link between E(2) action at the cell membrane and discrete biological actions in the cell has been strengthened. There is now convincing in vitro evidence that E(2) can modulate the functions of neural and vascular cells via non-genomic actions. Thus, the actions of discrete pools of E(2) receptors are likely to contribute to the overall effects of the sex steroids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295570     DOI: 10.1016/s1043-2760(01)00377-0

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  164 in total

1.  Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites.

Authors:  Vladimir Znamensky; Keith T Akama; Bruce S McEwen; Teresa A Milner
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 2.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

3.  Voltage-activated Ca(2+) channels and their role in the endocrine function of the pituitary gland in newborn and adult mice.

Authors:  Simon Sedej; Tetsuhiro Tsujimoto; Robert Zorec; Marjan Rupnik
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

Review 4.  Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.

Authors:  James H Segars; Paul H Driggers
Journal:  Trends Endocrinol Metab       Date:  2002-10       Impact factor: 12.015

5.  Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.

Authors:  Lianguo Kang; Lei Wang; Zhao-Yi Wang
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

6.  17beta-estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivo.

Authors:  Matthew P Rowan; Kelly A Berg; Stephen B Milam; Nathan A Jeske; James L Roberts; Kenneth M Hargreaves; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2010-07-20       Impact factor: 4.030

7.  Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampus.

Authors:  Katherine L Mitterling; Joanna L Spencer; Noelle Dziedzic; Sushila Shenoy; Katharine McCarthy; Elizabeth M Waters; Bruce S McEwen; Teresa A Milner
Journal:  J Comp Neurol       Date:  2010-07-15       Impact factor: 3.215

8.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

9.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

10.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.